(Q63832785)
Statements
A Phase la Trial of Photodynamic Therapy With HPPH (2-1 (Hexyloxyethyl)-2-devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Oral Cavity and/or Oropharynx. (English)
0 references
8 June 2010
0 references
29 January 2013
0 references
29
0 references
18 year
0 references